Pedro Lopez-Mondejar
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in adolescents and adults with cystic fibrosis and F508del-gating and F508del-residual function genotypes: results from an open-label extension study.
Journal: Annals of the American Thoracic Society
Published: October 03, 2025
Predictive factors of survival in people with Cystic fibrosis from a Spanish registry of rare diseases
Journal: Revista espanola de salud publica
Published: June 16, 2025
Elexacaftor/tezacaftor/ivacaftor for cystic fibrosis and rare CFTR variants: in vitro translation to a phase 3, double-blind, randomized, placebo-controlled trial, and real-world study.
Journal: American journal of respiratory and critical care medicine
Published: June 13, 2025
Genomic characterization of MRSA recovered from people with cystic fibrosis during two Spanish multicentre studies (2013 and 2021).
Journal: JAC-antimicrobial resistance
Published: July 24, 2024
Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study.
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: July 10, 2024
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 25, 2024
Longitudinal transcriptional immune profiles and persistent wheezing in moderate-to-late preterm infants.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: April 16, 2024
Maternal and fetal outcomes in multiparous women with Cystic Fibrosis.
Journal: Respiratory medicine
Published: October 29, 2023
SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge.
Journal: Pediatric pulmonology
Published: April 05, 2023
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.
Journal: American journal of respiratory and critical care medicine
Published: July 11, 2022
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 01, 2022
Analysis of the genotypic profile and its relationship with the clinical manifestations in people with cystic fibrosis: study from a rare disease registry.
Journal: Orphanet journal of rare diseases
Published: December 29, 2021
Last Updated: 09/26/2026